Updated On: 12 July, 2024 12:00 PM IST | New Delhi | IANS
he innovative approach, published in the journal Biomaterials, aims to enhance treatment efficacy for brain tumours, potentially offering new hope for improving outcomes in glioblastoma patients

Image for representational purpose only. Photo Courtesy: istock
A novel nanoformulation to cure deadly brain tumours has shown promise in pre-clinical trials, researchers at the Indian Institute of Technology (IIT) Delhi said on Thursday.
Glioblastoma, the most common and aggressive type of cancerous brain tumour in adults, poses significant treatment challenges despite available options like surgery, radiation, and chemotherapy.